Zongtai Wu

机构：University of Cambridge · ORCID：0000-0002-8609-1016

发表论文 18 篇 · 总被引 121 次 · h-index 6

代表论文

Efgartigimod as a promising add-on therapy for myasthenic crisis: a prospective case series (2024 · Frontiers in Immunology · 被引 32)
Patterns and predictors of therapeutic response to efgartigimod in acetylcholine receptor-antibody generalized myasthenia gravis subtypes (2025 · Therapeutic Advances in Neurological Disorders · 被引 23)
The safety and efficacy profile of eculizumab in myasthenic crisis: a prospective small case series (2024 · Therapeutic Advances in Neurological Disorders · 被引 18)
Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort study (2024 · Therapeutic Advances in Neurological Disorders · 被引 17)
Initiation response, maximized therapeutic efficacy, and post-treatment effects of biological targeted therapies in myasthenia gravis: a systematic review and network meta-analysis (2024 · Frontiers in Neurology · 被引 10)
Nomogram for predicting pregnancy-related relapse of myasthenia gravis (2024 · Orphanet Journal of Rare Diseases · 被引 6)